Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HNRNPH3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | ARL2BP | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | DZIP3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | CSTA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | C1orf74 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | ENTPD2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | THAP9 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | PARP2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | KIF13B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | TMEM45B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |